In which, interleukin‐6 (IL‐6) is found to increase the risk of future CAD, nonfatal myocardial infarction (MI), and CAD death3, 4, 5 with a magnitude of effect comparable, if not larger, than that of low‐density lipoprotein cholesterol (LDL‐C).6 This evidence concerns the gene IL6 and myocardial infarction.